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Objectives. The goal of this study was to determine the incre- 
mental prognostic value of left ventricular geometric patterns 
beyond that provided by cardiovascular disease risk factors, 
including left ventricular mass. 
Background. Left ventricular geometry may be classified into 
the following four mutually exclusive groups on the basis of left 
ventricular mass and relative wall thickness: concentric hyper- 
trophy (increased mass and increased relative wall thickness), 
eccentric hypertrophy (increased mass and normal relative 
wall thickness), concentric remodeling (normal mass and in- 
creased relative wall thickness) and normal geometry (normal 
mass and normal relative wall thickness). The prognosis 
associated with these patterns in a population-based sample is 
not known. 
Methods. Proportional hazards regression models were used to 
evaluate the prognostic importance of left ventricular geometry in 
3,216 subjects in the Framingham Heart Study who were >40 
years old and free of clinically apparent cardiovascular disease, 
after adjustment for traditional cardiovascular risk factors and 
left ventricular mass. The follow-up period was 8 years. 
Results. Subjects with concentric hypertrophy had the worst 
prognosis, followed by those with eccentric hypertrophy, concen- 
tric remodeling and normal geometry. Subjects with concentric 
hypertrophy also had the highest left ventricular mass. The 
association between type of geometry and prognosis was largely 
attenuated by adjustment for baseline differences in left ventric- 
ular mass. The odds ratio for incident cardiovascular disease in 
subjects with concentric hypertrophy compared with those who 
had normal geometry was 1.3 (95% confidence interval [CI] 0.8 to 
2.1) in men and 1.2 (95% CI 0.6 to 2.3) in women after adjustment for 
other cardiovascular risk factors, including left ventricular mass. 
Conclusions. In a population-based sample of subjects without 
cardiovascular disease, knowledge of left ventricular geometry 
provided little prognostic information beyond that available from 
left ventricular mass and traditional cardiovascular risk factors. 
(J Am Coil Cardioi 1995;25:879-84) 
The prognostic importance of left ventricular shape has been 
discussed for decades. Many early studies focused on the 
adaptation of the left ventricle to pressure or volume overload 
as a result of valvular disease (1-4); it was argued that 
concentric remodeling and hypertrophy were an adaptive 
response to pressure overload and were associated with a more 
favorable prognosis. More recent investigations (5-9) have 
considered left ventricular geometry in hypertensive patients. 
Investigators, using echocardiographic methods, have classi- 
fied the left ventricle into four mutually exclusive geometric 
patterns on the basis of left ventricular mass and relative wall 
thickness (the ratio of wall thickness to cavity diameter) (5-8). 
These geometric patterns are concentric hypertrophy (in- 
creased mass and increased relative wall thickness), eccentric 
hypertrophy (increased mass and normal relative wall thick- 
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ness), concentric remodeling (normal mass and increased 
relative wall thickness) and normal geometry (normal mass 
and normal relative wall thickness). 
The independent contribution of left ventricular geometry 
to prognosis is not known. Although concentric hypertrophy in
subjects with hypertension (5) and in the elderly (9) is reported 
to be associated with a less favorable prognosis, these studies 
did not adjust for differences in baseline left ventricular mass. 
Because previous reports from Framingham have demon- 
strated that left ventricular mass has a continuous and graded 
association with cardiovascular outcomes (10) and that con- 
centric hypertrophy is more common among subjects with 
more severe left ventricular hypertrophy (11), it is possible that 
the prognostic information from the geometric lassification 
derives largely from differences in left ventricular mass be- 
tween the groups. Accordingly, we examined data from the 
Framingham Heart Study and performed multivariable analy- 
sis to determine the incremental prognostic value of left 
ventricular geometric patterns beyond that provided by cardio- 
vascular disease risk factors, including left ventricular mass. 
Methods  
Study sample. In 1948, residents of Framingham, Massa- 
chusetts 28 to 62 years old were enrolled in a prospective 
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epidemiologic study (12,13). In 1971, children of the original 
cohort and spouses of those children were enrolled in the 
Framingham Offspring Study (14). Information about he base- 
line characteristics for this study were obtained in the years 
1979 to 1983, when members of the original cohort attended 
the 16th biennial examination and subjects in the Offspring 
Study attended the second examination. There was one excep- 
tion: data regarding plasma total cholesterol for the original 
cohort were obtained from the 15th biennial examination. To 
be eligible for this analysis, subjects had to be free of clinically 
apparent cardiovascular disease. The present study was re- 
stricted to subjects who were ->40 years old because few 
outcomes were expected in younger persons. 
Outcome vents. Incident cardiovascular disease and death 
were the outcomes of this study. At each examination, i terim 
cardiovascular disease events were identified by medical his- 
tory, physical examination, 12-lead electrocardiography and 
review of subjects' hospital records. Medical records routinely 
were obtained for participants who did not appear for an 
examination, and these were evaluated for evidence of incident 
cardiovascular disease. All suspected cardiovascular disease 
events were reviewed by three physicians, who evaluated the 
pertinent records. The cardiovascular disease events included 
in this study were coronary heart disease, congestive heart 
failure, stroke or transient ischemic attack and intermittent 
claudication. Coronary heart disease vents included angina 
pectoris, coronary insufficiency, myocardial infarction and sud- 
den or nonsudden death attributed to coronary heart disease. 
Criteria for the various cardiovascular disease events have 
been reported elsewhere (15). The baseline chocardiogram 
was not used to determine the presence or absence of cardio- 
vascular disease. 
All deaths were evaluated similarly, and the probable cause 
was established by a committee of three physicians after a 
review of the hospital records, autopsy findings, death certifi- 
cates and interviews with family members. Deaths in this study 
were classified as due to cardiovascular (coronary heart dis- 
ease, including sudden and nonsudden deaths, stroke and 
other cardiovascular causes) or noncardiovascular c uses. 
Echocardiographic methods. The M-mode echocardio- 
graphic methods used in the present study have been described 
elsewhere (16). Measurements of the internal diameter and 
wall thickness of the left ventricle were made at end-diastole, 
according to the methods of Devereux and Reichek (17). Left 
ventricular mass was calculated with the following formula: 
Left ventricular mass (g) = 1.04[(LVID + VST + PWT) 3 - 
(LVID) 3] - 13.6, where LVID = left ventricular internal 
diameter measured at end-diastole; VST = ventricular septal 
thickness; and PWT = posterior wall thickness. All values 
reported for left ventricular mass were divided by height. 
Relative wall thickness was calculated as follows: Relative wall 
thickness : (VST + PWT)/LVID. 
Cut points to identify left ventricular hypertrophy were set 
at 143 g/m for men and 102 g/m for women, corresponding to 
2 SD above the mean values for left ventricular mass in a 
healthy reference group (16). Subjects were also categorized 
on the basis of their relative wall thickness, using 0.45 as a cut 
point in accordance with other published reports (5-8). The 
sample was divided into four mutually exclusive groups on the 
basis of left ventricular geometry: concentric hypertrophy (left 
ventricular hypertrophy and increased relative wall thickness); 
eccentric hypertrophy (left ventricular hypertrophy and normal 
relative wall thickness); concentric remodeling (normal eft 
ventricular mass and increased relative wall thickness); and 
normal geometry (normal eft ventricular mass and normal 
relative wall thickness). 
Statistical analysis. Separate analyses were performed for 
men and women. To overcome problems of highly skewed 
distributions, natural ogarithmic transformation was applied 
to values of left ventricular mass, sum of wall thicknesses, left 
ventricular internal dimension and relative wall thickness 
before outcome analysis. Age-adjusted mean levels of echocar- 
diographic measurements of the four geometric patterns were 
calculated using analysis of covariance (18). 
The outcome vents were all cardiovascular disease and 
all-cause mortality. The follow-up period was roughly 8 years. 
Multivariable analyses were performed for subjects with com- 
plete risk factor information. The Cox proportional hazards 
model (19) was used to relate left ventricular geometry with 
outcomes. 
Hazard ratios were adjusted for several covariates, includ- 
ing age (years), systolic blood pressure (mm Hg), antihyper- 
tensive treatment ( hose subjects currently taking prescribed 
medication for the treatment of hypertension were assigned a
value of 1, and all others were assigned a value of 0), total 
cholesterol level (mg/dl), diabetes mellitus (yes = 1, no = 0), 
smoking (cigarettes/day), body mass index (Weight [kg]/ 
(Height) 2 [m]) and the presence of a greater than grade 2 
murmur on physical examination (yes = 1, no = 0). Diabetes 
mellitus was defined if any one of the following criteria was 
met: a fasting whole-blood glucose level ->7.77 mmol/liter (140 
mg/dl), a random nonfasting whole-blood glucose level 
_>11.11 mmol/liter (200 mg/dl) or the use of insulin or an oral 
hypoglycemic agent. 
All statistical analyses were carried out on a SUN Sparc 2 
Workstation with the Statistical Analysis System, Version 6.09; 
the procedure PHREG was used for proportional hazards 
regression modeling (20). A p value < 0.05 was used as the cut 
point to assess the statistical significance of each regression 
coefficient. 
Results 
Study sample. Of the 4,855 participants (2,180 men and 
2,675 women) >40 years old who attended the index exami- 
nation, 4,072 (1,765 men and 2,307 women) were free of 
cardiovascular disease (Table 1). Among these subjects, echo- 
cardiograms ofadequate quality to assess left ventricular mass 
were obtained for 1,400 men and 1,816 women; those with 
suboptimal echocardiographic examinations were older and 
had higher event rates than those with echocardiograms of 
adequate quality. Follow-up information was not available for 
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Table l. Sample Subjects and Incidence ofOutcome Events 
Men Women Total 
Seen at index examination 2,180 2,675 4,855 
(age -> 40 yr) 
Free of CVD 1,765 2,307 4,072 
Adequate quality 1,400 1,816 3,216 
echocardiogram 
Follow-up available 1,396 1,813 3,209 
Outcome vents 
Total CVD events 228 (16%) 171 (9%) 399 (12%) 
All-cause mortality 134 (10%) 125 (7%) 259 (8%) 
CVD mortality 43 (3%) 25 (1%) 68 (2%) 
Data presented are number (%) of study sample subjects. CVD = cardio- 
vascular disease. 
seven subjects, and they were not included in the analyses. 
During an average follow-up period of 7.7 years (range 0 to 
10.7) of eligible subjects, new cardiovascular disease events 
occurred in 399, and 259 died. 
Characteristics of the study sample are summarized in 
Table 2. The group was predominately middle-aged and nor- 
motensive. Approximately 20% of the subjects were taking 
antihypertensive medications. The women were slightly older 
than the men; they were more likely to be taking antihyper- 
tensive medications and to have a higher cholesterol level and 
a higher prevalence of left ventricular hypertrophy. In contrast, 
men had a higher diastolic blood pressure and a higher 
prevalence of smoking and diabetes. 
Left ventricular geometry. The majority of the study sam- 
ple had normal eft ventricular geometry (76% of men and 
72% of women). The remainder of the male sample was evenly 
distributed among the categories of concentric remodeling, 
eccentric hypertrophy and concentric hypertrophy, with ap- 
proximately 8% of the sample in each group. Among the 
women, 8% had concentric remodeling, 12% had eccentric 
hypertrophy, and 8% had concentric hypertrophy. 
The echocardiographic characteristics according to left 
Table 2. Clinical Characteristics of the Study Subjects 
Men Women 
Age (yr) 54.6 + 10.2 57.0 + 11.5 
Systolic blood pressure (ram Hg) 131 _+ 17 129 _+ 20 
Diastolic blood pressure (ram Hg) 81 ± 9 77 - 9 
Antihypertensive tr atment (%) 17.8 22.9 
Total cholesterol (mg/dl) 213 + 37 222 + 42 
Diabetes (%) 5.2 2.9 
Current smoker (%) 37 29 
Valvular disease (%) 2.9 2.4 
Body mass index (kg/m 2) 26.7 -+ 3.5 25.4 _+ 4.5 
Left ventricular mass (g/m)* 116 ± 34 87 _+ 27 
Left ventricular hypertrophy (%) 15.7 20.6 
Septal wall thickness (ram) 1/).0 + 1.6 8.9 _+ 1.6 
Posterior wall thickness (ram) 9.9 ± 1.5 8.8 ± 1.4 
Septal plus posterior wall thickness (ram) 19.9 ± 3.0 17.8 : 2.9 
Left ventricular internal dimension (mm) 50.6 + 4.3 45.4 ± 3.9 
Relative wall thickness x 100 40 ± 7 40 _+ 8 
*Adjusted for height. Data presented are mean value _+ SD or % prevalence. 
ventricular geometry are presented inTable 3. The group with 
normal geometry had the smallest mean values for left ven- 
tricular mass, followed by those with concentric remodeling, 
eccentric hypertrophy and concentric hypertrophy. Wall thick- 
ness values were lowest in the normal group, highest in the 
concentric hypertrophy group and intermediate in the other 
two groups. Left ventricular internal dimension was smallest in 
the group with concentric remodeling and largest in those with 
eccentric hypertrophy. Relative wall thickness was greatest in 
the concentric hypertrophy group and only slightly less in the 
concentric remodeling roup. 
Left ventricular geometry and outcomes. The event rates 
among men and women were highest in the concentric hyper- 
trophy group and lowest in the normal geometry group. After 
adjustment for traditional cardiovascular risk factors, this 
trend persisted. In women, concentric hypertrophy compared 
with normal geometry was associated with an odds ratio of 1.6 
(95% confidence interval [CI] 1.0 to 2.6) for total cardiovas- 
cular events and 1.5 (95% CI 0.9 to 2.5) for all-cause mortality 
(Table 4). In men, concentric hypertrophy compared with 
normal geometry was associated with an odds ratio of 2.1 (95% 
C! 1.5 to 3.1) for total cardiovascular events and 2.1 (95% CI 
1.3 to 3.4) for all-cause mortality. 
Adjustment for left ventricular mass in addition to the other 
risk factors attenuated the association of geometry group with 
outcome both for cardiovascular disease and for all-cause 
mortality (Table 4). In men, for example, the hazard ratio for 
concentric hypertrophy compared with normal geometry was 
1.3 (95% CI 0.8 to 2.1) for total cardiovascular events and 1.7 
(95% CI 0.8 to 3.5) for all-cause mortality. In women, the odds 
ratio for concentric hypertrophy compared with normal geom- 
etry was 1.2 (95% CI 0.6 to 2.3) for total cardiovascular events 
and 1.1 (95% CI 0.5 to 2.3) for all-cause mortality. There were 
no significant differences among the geometric patterns for 
either outcome in men or women. 
Discuss ion  
A common classification system of left ventricular geometry 
is based on left ventricular mass and relative wall thickness 
(5-9). In our population-based sample, 24% of the men and 
28% of the women had abnormal geometric patterns. These 
subjects were distributed in nearly equal numbers among 
concentric remodeling, eccentric hypertrophy and concentric 
hypertrophy. Classification systems can be useful if they pro- 
vide convenient ways to convey etiologic, prognostic or thera- 
peutic information. Previous investigators (6-9) have sug- 
gested that the use of echocardiography to classify the left 
ventricle into geometric groups has prognostic utility. These 
studies did not address whether information about the geo- 
metric pattern of the left ventricle complements prognostic 
information conveyed by left ventricular mass. Our principal 
finding is that much of the prognostic importance conveyed by 
left ventricular geometry is explained by baseline differences in
left ventricular mass. 
A previous report from the Framingham Heart Study 
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Table 3. Age-Adjusted Echocardiographic Measurements by Left Ventricular Geometric Pattern 
Men Women 
Concentric Eccentric Concentric Concentric Eccentric Concentric 
Normal Remodeling Hypertrophy Hypertrophy Normal Remodeling Hypertrophy Hypertrophy 
(n - 1,063) (n = 114) (n 109) (n 110) (n - 1,302) (n - 137) (n - 220) (n = 154) 
LV mass (g/m) 103.7 (0.72) 115.3 (2.21) 165.6 (2.24) 179.7 (2.25) 76.6 (0.50) 83.1 (1.56) 117.6 (1.19) 132.5 (1.50) 
VST (ram) 9.4 (0.03) 11.4 (0.09) 11.1 (0.09) 13.4 (0.09) 8.3 (0.03) 9.8 (0.08) 9.7 (0.06) 12.3 (0.08) 
PWT (mm) 9.4 (0.03) 11.2 (0.09) 11.1 (0.09) 13.0 (0.09) 8.3 (0.02) 9.8 (0.07) 9.6 (0.06) 11.7 (0.07) 
SWT (mm) 18.8 (0.06) 22.6 (0.18) 22.2 (0.18) 26.4 (0.18) 16.6 (0.05) 19.6 (0.14) 19.3 (0.11) 24.0 (0.14) 
LV1D (mm) 50.4 (0.11) 45.6 (0.34) 57.0 (0.34) 51.0 (0.34) 45.2 (0.09) 41.0 (0.28) 50.4 (0.22) 43.9 (0.27) 
RWT (%) 37.4 (0.14) 49.7 (0.42) 39.1 (0.43) 52.2 (0.43) 36.9 (0.14) 48.1 (0.42) 38.4 (0.32) 55.7 (0.41) 
Data presented are adjusted mean values (SE), computed separately for men and women by analysis of covariance. LVID = left ventricular internal dimension 
at end-diastole; LV mass = left ventricular mass (divided by height); PWT = posterior wall thickness; RWT - relative wall thickness; SWT = sum of wall thicknesses; 
VST = ventricular septal thickness. 
demonstrated that subjects with left ventricular hypertrophy 
may manifest different geometric patterns. In that report, 
Savage t al. (11) found that subjects with concentric hyper- 
trophy had more severe left ventricular hypertrophy. Another 
report from the Framingham Heart Study (10) documented 
the association of increased left ventricular mass with risk of 
cardiovascular disease. We extend the previous observations by 
showing that left ventricular geometry is associated with out- 
comes largely through its association with left ventricular mass. 
In the Framingham cohort, left ventricular mass was lowest in 
the group with a normal geometric pattern and increased 
progressively from the group with concentric remodeling to 
eccentric hypertrophy to concentric hypertrophy. The dichot- 
omous variable of left ventricular hypertrophy masked sub- 
stantial differences in left ventricular mass between those with 
concentric and eccentric hypertrophy. Mean left ventricular 
mass in the subjects with eccentric hypertrophy was 166 g/m for 
men and 118 g/m for women compared with 180 g/m for men 
and 133 g/m for women in the group with concentric hyper- 
trophy. Similarly, there were substantial differences in left 
ventricular mass between subjects with normal geometry and 
those with concentric remodeling. 
Previous studies. Our unadjusted analysis confirms the 
observations ofKoren et al. (5). They tallied event rates for 150 
hypertensive subjects with normal geometry, 34 subjects with 
concentric remodeling, 40 subjects with eccentric hypertrophy 
and 29 subjects with concentric hypertrophy. Patients with 
concentric hypertrophy had the greatest risk of mortality, 
followed by patients with eccentric hypertrophy and those with 
concentric remodeling. 
Our findings differ from the report of Aronow et al. (9) in 
a study of hypertensive lderly subjects. After -3 years of 
follow-up, they found that concentric hypertrophy was associ- 
ated with the highest coronary event rate. On the basis of 
Table 4. Hazard Ratios and 95% Confidence Intervals for Outcome Events Based on Left Ventricular Geometric Pattern Adjusted for Age 
and Risk Factors 
Men Women 
Hazard Ratio Hazard Ratio Hazard Ratio Hazard Ratio 
Predictor Outcomc Unadjusted Adjusted for Outcome Unadjusted for Adjusted for 
Variable Events for LV Mass* LV Masst Events LV Mass* LV Masst 
Normal n - 1,063 n 1,302 
Total CVD 143 (13%) 1.0 1.0 82 (6%) 1.0 1.0 
All-cause mortality 78 (7%) 1.0 1.0 55 (4%) 1.0 1.0 
Concentric remodeling n - 114 n = 137 
Total CVD 20 (18%) 1.0 (0.6-1.7) 0.9 (0.6-1.5) 21 (15%) 1.3 (0.8-2.3) 1.3 (0.7-2.2) 
All-cause mortality 15 (13%) 1.3 (0.7-2.3) 1.2 (0.7-2.2) 17 (12%) 1.1 (0.6-2.1) 1.1 (0.6-2.0) 
Eccentric hypertrophy n - 109 n = 220 
Total CVD 24 (22%) 1.1 (0.6-1.7) 0.8 (0.4-1.3) 32 (15%) 1.5 (1.0-2.5) 1.2 (0.7-2.2) 
All-cause mortality 16 (15%) 1.7 (0.9-3.0) 1.4 (0.7-2.9) 21 (10%) 1.3 (0.8-2.3) 1.1 (0.5-2.1) 
Concentric hypertrophy n 110 n - 154 
Total CVD 41 (37%) 2.1 (1.5-3.1) 1.3 (0.8-2.1) 36 (23%) 1.6 (1.0-2.6) 1.2 (0.6-2.3) 
All-cause mortality 25 (23%) 2.1 (1.3-3.4) 1.7 (0.8-3.5) 32 (21%) 1.5 (0.9-2.5) 1.1 (0.5-2.3) 
*Hazard ratios are compared with 1.(I, the value for the reference group of men and women with normal geometry, respectively; these hazard ratios, derived from 
the proportional hazards model, have been adjusted for age, systolic blood pressure (ram Hg), total cholesterol (mg/dl), diabetes (no/yes), body mass index (kg/m2), 
antihypertensive m dication (no/yes), smoking (cigarettes/day) and presence of a greater than grade 2 murmur on physical examination ( o/yes). tValues shown for 
hazard ratios are compared with 1.0, the value for the reference group of men and women with normal geometry; these hazard ratios also have been adjusted for the 
previous covariates and left ventricular (LV) mass. Values in parentheses are 95% confidence intervals. CVD = cardiovascular disease. 
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multiple logistic regression analyses, they reported that the 
most important predictors of coronary events were the pres- 
ence of left ventricular hypertrophy, total serum cholesterol 
level and presence of concentric left ventricular hypertrophy. 
Although these investigators included left ventricular hyper- 
trophy in their model, they did not adjust for baseline differ- 
ences in left ventricular mass. The stratification of patients by 
the presence of left ventricular hypertrophy may obscure 
important differences in risk that are related to differences in
left ventricular mass. Because left ventricular mass appears to 
have a graded and continuous association with outcome (10), 
the use of hypertrophy for the purpose of risk assessment may 
be insufficient. 
Gender differences. There were some interesting ender 
differences in this study. Adjustment for left ventricular mass 
virtually eliminated any association between geometry and 
outcome in women; however, in men there remained a ten- 
dency toward increased risk for all-cause mortality for each 
group with abnormal geometry compared with the normal 
group. In addition, there was a trend toward an increased rate 
of cardiovascular events in the concentric hypertrophy group 
compared with the normal group. These differences deserve 
further investigation. Other studies (21-23) have reported 
gender differences instructural daptation tohypertension a d 
physiologic response to stress. 
Study limitations. The most important limitation of this 
study is its sample size. Because this is a prospective observa- 
tional study, there was no opportunity to increase the size of 
each geometric pattern group. We analyzed men and women 
separately because of evidence that there may be important 
gender differences in left ventricular geometry. To our knowl- 
edge, the present study represents the largest long-term 
follow-up of patients classified according to left ventricular 
geometric pattern; however, it lacks sufficient power to declare 
definitively that there is no association between geometric 
pattern and outcome. Post hoc analysis indicated that the study 
had 80% power to detect a twofold difference in risk of 
cardiovascular disease when each group with abnormal geom- 
etry was compared with the normal group. Effects of lesser 
magnitude may also be important, but the study had only a 
40% power to detect a 1.5-fold risk increase. Therefore, the 
present study can only conclude that there is little evidence 
that classification by left ventricular geometry provides ub- 
stantial prognostic information beyond that available from 
mass and traditional cardiovascular risk factors. In the present 
sample, left ventricular mass was predictive of risk, but geom- 
etry was less so. 
The relevance of these results to other racial groups is not 
known because the Framingham Heart Study sample is pre- 
dominately white. Hypertensive hypertrophic cardiomyopathy 
in the elderly, a condition of severe concentric hypertrophy 
that is associated with increased risk for cardiovascular events, 
may be more common in African-Americans (24). Studies of 
the importance of left ventricular geometry in more heteroge- 
neous populations are needed. 
Finally, the use of M-mode echocardiography to classify 
subjects has its limitations. This classification method cannot 
fully characterize three-dimensional left ventricular geometry. 
In addition, there are difficulties with the use of M-mode 
echocardiography because measurements may be inaccurate as 
a result of the beam angle. However, these errors were not 
likely to be biased because the measurements were made by 
investigators who had no knowledge of the outcomes. In 
addition, subjects in this study were free of clinically apparent 
coronary artery disease, the condition that presents the great- 
est difficulty with the validity of M-mode measurement. Nev- 
ertheless, even under the best conditions, this classification 
system will not always characterize three-dimensional left 
ventricular geometry. Finally, these results are not generaliz- 
able to the sample of patients for whom adequate M-mode 
measures could not be obtained. 
Conclusions. Framingham Heart Study subjects who were 
free of cardiovascular disease had a prevalence of abnormal 
left ventricular geometry of -24% in men and -28% in 
women. The use of echocardiography to classify left ventricular 
geometry provided little incremental prognostic information 
beyond left ventricular mass and other cardiovascular risk 
factors. Although left ventricular geometry was associated with 
cardiovascular events and all-cause mortality, it was also 
associated with differences in left ventricular mass. Adjustment 
for cardiovascular risk factors and left ventricular mass atten- 
uated the strength of the association of geometric patterns with 
outcomes. 
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